These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 33472525)
41. Factors influencing the survival period in Japanese patients with sporadic Creutzfeldt-Jakob disease. Iwasaki Y; Akagi A; Mimuro M; Kitamoto T; Yoshida M J Neurol Sci; 2015 Oct; 357(1-2):63-8. PubMed ID: 26143527 [TBL] [Abstract][Full Text] [Related]
42. Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease. Pascuzzo R; Oxtoby NP; Young AL; Blevins J; Castelli G; Garbarino S; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Alexander DC; Bizzi A Acta Neuropathol; 2020 Aug; 140(2):169-181. PubMed ID: 32535770 [TBL] [Abstract][Full Text] [Related]
43. Focal sharp waves are a specific early-stage marker of the MM2-cortical form of sporadic Creutzfeldt-Jakob disease. Matsubayashi T; Akaza M; Hayashi Y; Hamaguchi T; Yamada M; Shimohata T; Yokota T; Sanjo N Prion; 2020 Dec; 14(1):207-213. PubMed ID: 32787547 [TBL] [Abstract][Full Text] [Related]
44. An autopsy-verified case of FTLD-TDP type A with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease. Hayashi Y; Iwasaki Y; Takekoshi A; Yoshikura N; Asano T; Mimuro M; Kimura A; Satoh K; Kitamoto T; Yoshida M; Inuzuka T Prion; 2016 Nov; 10(6):492-501. PubMed ID: 27929803 [TBL] [Abstract][Full Text] [Related]
46. Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients. Jansen C; Head MW; Rozemuller AJ; Ironside JW Neuropathol Appl Neurobiol; 2009 Jun; 35(3):272-82. PubMed ID: 19473294 [TBL] [Abstract][Full Text] [Related]
47. Creutzfeldt-Jakob disease with an M232R substitution: report of a patient showing slowly progressive disease with abundant plaque-like PrP deposits in the cerebellum. Shimizu H; Yamada M; Matsubara N; Takano H; Umeda Y; Kawase Y; Kitamoto T; Nishizawa M; Takahashi H Neuropathology; 2009 Dec; 29(6):735-43. PubMed ID: 19422537 [TBL] [Abstract][Full Text] [Related]
48. Gerstmann-Straeussler-Scheinker disease with P102L prion protein gene mutation presenting with rapidly progressive clinical course. Iwasaki Y; Mori K; Ito M; Nokura K; Tatsumi S; Mimuro M; Kitamoto T; Yoshida M Clin Neuropathol; 2014; 33(5):344-53. PubMed ID: 24986180 [TBL] [Abstract][Full Text] [Related]
49. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531 [TBL] [Abstract][Full Text] [Related]
50. Clinical Presentation of Sporadic Creutzfeldt-Jakob Disease in Han-Chinese. Chen S; He S; Xu YY; Teng HY; Zhang JW Alzheimer Dis Assoc Disord; 2020; 34(2):188-190. PubMed ID: 31651418 [TBL] [Abstract][Full Text] [Related]
52. Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings. Baiardi S; Capellari S; Ladogana A; Strumia S; Santangelo M; Pocchiari M; Parchi P J Alzheimers Dis; 2016; 50(2):465-76. PubMed ID: 26682685 [TBL] [Abstract][Full Text] [Related]
53. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report. Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975 [TBL] [Abstract][Full Text] [Related]
54. Long-term preservation of pharyngeal swallowing function in MM2-cortical-type sporadic Creutzfeldt-Jakob disease. Hayashi Y; Kunieda K; Kudo T; Kimura A; Fujishima I; Shimohata T Prion; 2021 Dec; 15(1):82-86. PubMed ID: 34078217 [TBL] [Abstract][Full Text] [Related]
55. Predictive Factors for Early Initiation of Artificial Feeding in Patients With Sporadic Creutzfeldt-Jakob Disease. Hsieh PC; Li HT; Chang CW; Wu YR; Kuo HC Front Neurol; 2018; 9():496. PubMed ID: 30018588 [No Abstract] [Full Text] [Related]
56. Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. Otto A; Zerr I; Lantsch M; Weidehaas K; Riedemann C; Poser S J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):524-8. PubMed ID: 9576547 [TBL] [Abstract][Full Text] [Related]
57. Clinical findings of a probable case of MM2-cortical-type sporadic Creutzfeldt-Jakob disease with antibodies to anti-N-terminus of α-enolase. Hayashi Y; Yamada M; Kimura A; Asano T; Satoh K; Kitamoto T; Yoneda M; Inuzuka T Prion; 2017 Nov; 11(6):454-464. PubMed ID: 28967811 [TBL] [Abstract][Full Text] [Related]